Tianjun Song 3/17/23 Tianjun Song 3/17/23 YS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQ Read More Tianjun Song 3/10/23 Tianjun Song 3/10/23 Biocytogen Announces RenLite® Licensing Agreement with Janssen Read More Tianjun Song 3/3/23 Tianjun Song 3/3/23 Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376 Read More Tianjun Song 2/24/23 Tianjun Song 2/24/23 Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901 Read More Tianjun Song 2/20/23 Tianjun Song 2/20/23 Cullinan Oncology Licenses U.S. Rights to the First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator from Harbour BioMed Read More Tianjun Song 2/20/23 Tianjun Song 2/20/23 Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) Read More Tianjun Song 2/20/23 Tianjun Song 2/20/23 Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares Read More Tianjun Song 11/8/22 Tianjun Song 11/8/22 Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion Read More Tianjun Song 10/28/22 Tianjun Song 10/28/22 Ascletis announce signing license and supply agreement of ritonavir for COVID-19 drug PAXLOVID™ in mainland China With Pfizer Read More Tianjun Song 10/28/22 Tianjun Song 10/28/22 XtalPi Announces Research Collaboration with Janssen Read More Tianjun Song 10/28/22 Tianjun Song 10/28/22 JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies Read More Ning Feng 10/26/22 Ning Feng 10/26/22 HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers Read More Ning Feng 10/24/22 Ning Feng 10/24/22 C4XD and HitGen to collaborate in inflammation hit identification project Read More Ning Feng 10/11/22 Ning Feng 10/11/22 IASO Biotherapeutics and Cabaletta Bio Announce Exclusive Worldwide License Agreement for Clinically Validated CD19 Binder Read More Ning Feng 9/29/22 Ning Feng 9/29/22 Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc Read More Ning Feng 9/27/22 Ning Feng 9/27/22 Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK® (tisotumab vedotin-tftv) Read More Ning Feng 9/21/22 Ning Feng 9/21/22 Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China Read More Ning Feng 9/14/22 Ning Feng 9/14/22 METiS Announces Pan-RAF Inhibitor License Agreement with Voronoi Read More Guest User 8/21/22 Guest User 8/21/22 Elevation Oncology Expands Pipeline through Exclusive Licensing of EO-3021 (SYSA1801), a Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate, From CSPC Pharmaceutical Group Read More Guest User 8/21/22 Guest User 8/21/22 Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China Read More Newer Posts Older Posts
Tianjun Song 3/17/23 Tianjun Song 3/17/23 YS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQ Read More
Tianjun Song 3/10/23 Tianjun Song 3/10/23 Biocytogen Announces RenLite® Licensing Agreement with Janssen Read More
Tianjun Song 3/3/23 Tianjun Song 3/3/23 Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376 Read More
Tianjun Song 2/24/23 Tianjun Song 2/24/23 Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901 Read More
Tianjun Song 2/20/23 Tianjun Song 2/20/23 Cullinan Oncology Licenses U.S. Rights to the First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator from Harbour BioMed Read More
Tianjun Song 2/20/23 Tianjun Song 2/20/23 Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) Read More
Tianjun Song 2/20/23 Tianjun Song 2/20/23 Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares Read More
Tianjun Song 11/8/22 Tianjun Song 11/8/22 Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion Read More
Tianjun Song 10/28/22 Tianjun Song 10/28/22 Ascletis announce signing license and supply agreement of ritonavir for COVID-19 drug PAXLOVID™ in mainland China With Pfizer Read More
Tianjun Song 10/28/22 Tianjun Song 10/28/22 XtalPi Announces Research Collaboration with Janssen Read More
Tianjun Song 10/28/22 Tianjun Song 10/28/22 JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies Read More
Ning Feng 10/26/22 Ning Feng 10/26/22 HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers Read More
Ning Feng 10/24/22 Ning Feng 10/24/22 C4XD and HitGen to collaborate in inflammation hit identification project Read More
Ning Feng 10/11/22 Ning Feng 10/11/22 IASO Biotherapeutics and Cabaletta Bio Announce Exclusive Worldwide License Agreement for Clinically Validated CD19 Binder Read More
Ning Feng 9/29/22 Ning Feng 9/29/22 Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc Read More
Ning Feng 9/27/22 Ning Feng 9/27/22 Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK® (tisotumab vedotin-tftv) Read More
Ning Feng 9/21/22 Ning Feng 9/21/22 Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China Read More
Ning Feng 9/14/22 Ning Feng 9/14/22 METiS Announces Pan-RAF Inhibitor License Agreement with Voronoi Read More
Guest User 8/21/22 Guest User 8/21/22 Elevation Oncology Expands Pipeline through Exclusive Licensing of EO-3021 (SYSA1801), a Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate, From CSPC Pharmaceutical Group Read More
Guest User 8/21/22 Guest User 8/21/22 Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China Read More
